BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15485904)

  • 21. Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.
    Hellwig S; Miduturu CV; Kanda S; Zhang J; Filippakopoulos P; Salah E; Deng X; Choi HG; Zhou W; Hur W; Knapp S; Gray NS; Smithgall TE
    Chem Biol; 2012 Apr; 19(4):529-40. PubMed ID: 22520759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region.
    Read RD; Lionberger JM; Smithgall TE
    J Biol Chem; 1997 Jul; 272(29):18498-503. PubMed ID: 9218495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.
    Shaffer JM; Hellwig S; Smithgall TE
    Biochemistry; 2009 Jun; 48(22):4780-8. PubMed ID: 19382747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B.
    Vadlamudi RK; Barnes CJ; Rayala S; Li F; Balasenthil S; Marcus S; Goodson HV; Sahin AA; Kumar R
    Mol Cell Biol; 2005 May; 25(9):3726-36. PubMed ID: 15831477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microtubule-associated protein 1B interaction with tubulin tyrosine ligase contributes to the control of microtubule tyrosination.
    Utreras E; Jiménez-Mateos EM; Contreras-Vallejos E; Tortosa E; Pérez M; Rojas S; Saragoni L; Maccioni RB; Avila J; González-Billault C
    Dev Neurosci; 2008; 30(1-3):200-10. PubMed ID: 18075266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GCP6 binds to intermediate filaments: a novel function of keratins in the organization of microtubules in epithelial cells.
    Oriolo AS; Wald FA; Canessa G; Salas PJ
    Mol Biol Cell; 2007 Mar; 18(3):781-94. PubMed ID: 17182859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophosphorylation of the Fes tyrosine kinase. Evidence for an intermolecular mechanism involving two kinase domain tyrosine residues.
    Rogers JA; Read RD; Li J; Peters KL; Smithgall TE
    J Biol Chem; 1996 Jul; 271(29):17519-25. PubMed ID: 8663427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Truncation of c-fes via gene targeting results in embryonic lethality and hyperproliferation of hematopoietic cells.
    Hackenmiller R; Simon MC
    Dev Biol; 2002 May; 245(2):255-69. PubMed ID: 11977979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
    Delfino FJ; Stevenson H; Smithgall TE
    J Biol Chem; 2006 Mar; 281(13):8829-35. PubMed ID: 16455651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human c-FES is a nuclear tyrosine kinase.
    Yates KE; Lynch MR; Wong SG; Slamon DJ; Gasson JC
    Oncogene; 1995 Mar; 10(6):1239-42. PubMed ID: 7700650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FES/FER kinase signaling in hematopoietic cells and leukemias.
    Craig AW
    Front Biosci (Landmark Ed); 2012 Jan; 17(3):861-75. PubMed ID: 22201778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FES kinase promotes mast cell recruitment to mammary tumors via the stem cell factor/KIT receptor signaling axis.
    Kwok E; Everingham S; Zhang S; Greer PA; Allingham JS; Craig AW
    Mol Cancer Res; 2012 Jul; 10(7):881-91. PubMed ID: 22589410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression, purification and preliminary crystallographic studies on the catalytic region of the nonreceptor tyrosine kinase Fes.
    Gnemmi I; Scotti C; Cappelletti D; Canonico PL; Condorelli F; Rosano C
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):18-20. PubMed ID: 17183165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An identity crisis for fps/fes: oncogene or tumor suppressor?
    Sangrar W; Zirgnibl RA; Gao Y; Muller WJ; Jia Z; Greer PA
    Cancer Res; 2005 May; 65(9):3518-22. PubMed ID: 15867340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial and temporal changes in the subcellular localization of the nuclear protein-tyrosine kinase, c-Fes.
    Carlson A; Yates KE; Slamon DJ; Gasson JC
    DNA Cell Biol; 2005 Apr; 24(4):225-34. PubMed ID: 15812239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo characterization of pp39mos association with tubulin.
    Zhou RP; Shen RL; Pinto da Silva P; Vande Woude GF
    Cell Growth Differ; 1991 May; 2(5):257-65. PubMed ID: 1832292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleckstrin homology domains of phospholipase C-gamma1 directly interact with beta-tubulin for activation of phospholipase C-gamma1 and reciprocal modulation of beta-tubulin function in microtubule assembly.
    Chang JS; Kim SK; Kwon TK; Bae SS; Min DS; Lee YH; Kim SO; Seo JK; Choi JH; Suh PG
    J Biol Chem; 2005 Feb; 280(8):6897-905. PubMed ID: 15579910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-expression with BCR induces activation of the FES tyrosine kinase and phosphorylation of specific N-terminal BCR tyrosine residues.
    Li J; Smithgall TE
    J Biol Chem; 1996 Dec; 271(51):32930-6. PubMed ID: 8955135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.